STOCK TITAN

Monogram Technologies insider grant: 40,000 options to CFO Knape

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Noel Knape, Chief Financial Officer and Director of Monogram Technologies Inc. (MGRM), reported a transaction on Form 4 showing an award of derivative securities. The filing reports that on 01/08/2025 Mr. Knape was granted 40,000 stock options with an exercise price of $2.50. The options have a date exercisable of 01/08/2032 and an expiration date of 01/08/2035, and the underlying security is common stock. The Form identifies Mr. Knape’s address in Austin, TX and is signed by him on 09/30/2025. The filing includes an explanatory note that the company uses the Black-Scholes-Merton model to determine fair value of stock awards.

Positive

  • 40,000 stock options granted to CFO/Director Noel Knape (transaction date 01/08/2025)
  • Exercise price disclosed at $2.50
  • Clear exercisable and expiration dates provided: exercisable 01/08/2032, expiration 01/08/2035
  • Form is signed by the reporting person (09/30/2025)

Negative

  • None.

Insights

TL;DR: Routine executive option grant of 40,000 options at $2.50, long-dated vesting/exercise period; no other transactions disclosed.

The Form 4 discloses a single derivative award to the CFO and director: 40,000 stock options granted 01/08/2025 with an exercise price of $2.50, exercisable beginning 01/08/2032 and expiring 01/08/2035. This is a disclosure of insider compensation rather than a disposition or sale. The filing also states the company values awards using the Black-Scholes-Merton model. From a reporting perspective the form is complete with reporting person details and signature date.

TL;DR: Governance disclosure shows an officer received a long-dated option award; filing appears standard and properly executed.

The reporting person is identified as both an officer (CFO) and director, and the Form 4 records the grant of 40,000 options. Dates and terms (exercise price $2.50, exercisable 01/08/2032, expiring 01/08/2035) are provided and the form is signed. The explanatory note about Black-Scholes valuation is included. The disclosure is consistent with routine equity-compensation reporting obligations under Section 16.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Knape Noel

(Last) (First) (Middle)
3913 TODD LANE

(Street)
AUSTIN TX 78744

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Monogram Technologies Inc. [ MGRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $2.5 01/08/2025 A 40,000 01/08/2032 01/08/2035 Common Stock 40,000 (1) 40,000 D
Explanation of Responses:
1. The Company uses the Black-Scholes-Merton ("Black-Scholes") option-pricing model to determine the fair value of stock awards. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, including the estimated fair value and price volatility of the Company's common stock and the expected term of the option.
/s/ Noel Knape 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Noel Knape report on the Form 4 for Monogram Technologies (MGRM)?

The Form 4 reports a grant of 40,000 stock options to Noel Knape with an exercise price of $2.50, transaction date 01/08/2025.

When are the options exercisable and when do they expire?

The options are listed as exercisable on 01/08/2032 and expiring on 01/08/2035.

What role does the reporting person hold at MGRM?

The filing identifies Noel Knape as a Director and as an Officer (Chief Financial Officer) of Monogram Technologies.

What valuation method does the company use for stock awards as noted in the filing?

The filing states the company uses the Black-Scholes-Merton option-pricing model to determine fair value of stock awards.

When was the Form 4 signed by the reporting person?

The Form 4 is signed by Noel Knape on 09/30/2025.
Monogram Orthopaedics Inc

NASDAQ:MGRM

MGRM Rankings

MGRM Latest News

MGRM Latest SEC Filings

MGRM Stock Data

243.79M
18.47M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN